Ofatumumab as a Combination Therapy Versus Other Treatment Regimens in Patients With Untreated, Relapsed or Refractory Chronic Lymphocytic Leukaemia: A Systematic Review of Randomised Controlled Trials
Value in Health - United Kingdom
doi 10.1016/j.jval.2016.09.2078